ALX Oncology Holdings Inc. (ALXO) vs Journey Medical Corporation (DERM)
A side-by-side comparison of ALX Oncology Holdings Inc. and Journey Medical Corporation across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ALXO
ALX Oncology Holdings Inc.
$1.15HealthcareDelayed quote: Oct 6, 2026, 10:44 AM EDT
DERM
Journey Medical Corporation
$6.55HealthcareDelayed quote: Oct 6, 2026, 10:40 AM EDT
Total return — ALXO vs DERM
growth of $100 · dividends reinvested · last 5yALXO -97.2% (-51.2%/yr)DERM -29.6% (-6.8%/yr)DERM compounded faster over this window
Log scale — wide-divergence pair
ALXO DERM
ALXO vs DERM: by the numbers
- •DERM is the larger company ($180M vs $155M market cap).
- •Both run net losses; ALXO's is the smaller (0.00% vs -8.95% net margin).
Metrics side by side
Valuation
| Metric | ALXO | DERM |
|---|---|---|
| P/S ratio | N/A | 2.64 |
| P/B ratio | 1.14 | 5.62 |
| EV / EBITDA | N/A | 142.81 |
Profitability
| Metric | ALXO | DERM |
|---|---|---|
| Gross margin | 0.00% | 62.24% |
| Operating margin | 0.00% | -13.21% |
| Net margin | 0.00% | -8.95% |
| ROE | -59.40% | -19.01% |
| ROIC | -56.53% | -5.22% |
Growth (annualized)
| Metric | ALXO | DERM |
|---|---|---|
| Revenue CAGR (5Y) | N/A | 6.75% |
| Total return CAGR (5Y) | -56.07% | N/A |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.